CLYM
Climb Bio Inc
NASDAQ: CLYM · HEALTHCARE · BIOTECHNOLOGY
$8.88
+1.14% today
Updated 2026-04-30
Market cap
$436.60M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.88
Dividend yield
—
52W range
$1 – $10
Volume
0.6M
Climb Bio Inc (CLYM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.01M | $-14.10M | $-36.07M | $-37.37M | $-20.60M | $-15.56M | $-54.36M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $186000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | — | $707000.00 | $3.74M | $6.99M | $12.81M | $5.56M | $8.05M |
| Free cash flow | $-5.01M | $-14.10M | $-36.07M | $-37.37M | $-20.60M | $-15.56M | $-54.54M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |